Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Conservative versus proactive care after EUS-guided gallbladder drainage for acute cholecystitis

Official title: Conservative Versus Proactive Management of Acute Cholecystitis After EUS-guided Transmural Gallbladder Drainage. Multicenter Randomized Clinical Trial: FUGITIVE Trial (FUGITIVE)

Run by Hospital General Universitario de Alicante · NCT06967597 · Data updated 2026-11-12

This trial will test whether, for people with acute cholecystitis who cannot have surgery, keeping the endoscopic gallbladder stent in place long-term or doing regular endoscopic cleanings and removing the stent works better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment82 (estimated)
SponsorHospital General Universitario de Alicante
Academic / other
Locations2 sites (Alicante, Alicante and 1 other locations)
StatusRecruiting
StartedJune 1, 2025
Main results expectedJune 1, 2026
Study endsJune 1, 2027
Registry record updatedJune 10, 2025
Trial IDNCT06967597 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with confirmed acute cholecystitis per Tokyo 2018 who are unfit for cholecystectomy (for example age ≥80, ASA ≥III, high comorbidity burden, or low functional status) and who have received EUS-GBD with a LAMS are ideal candidates.

Probably not a fit

Patients who are suitable candidates for standard cholecystectomy, those with altered gastrointestinal anatomy preventing endoscopic access, severe coagulopathy, very short life expectancy, or inability to tolerate sedation are unlikely to receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study enrolls adults with acute cholecystitis who are unfit for surgery and have undergone EUS-guided transmural gallbladder drainage with a lumen-apposing metal stent (LAMS). Participants are assigned to conservative management with indefinite retention of the LAMS or to a proactive strategy involving scheduled endoscopic cholecystoscopy, gallstone removal, and stent revision or removal. Outcomes include recurrent cholecystitis, procedure-related complications, need for additional drainage or surgery, and stent-related adverse events over planned follow-up. The trial procedures are performed at a single center by experienced endoscopists using standard endoscopic techniques.

Why it matters

Potential benefit: If successful, the results could identify the safer, more effective follow-up approach to prevent recurrent gallbladder infections and reduce stent-related complications in patients who cannot have surgery.

How similar studies have gone: Previous studies suggest EUS-guided gallbladder drainage can have fewer complications than percutaneous drainage, but evidence is limited and conflicting about the best long-term management of LAMS.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient ≥ 18 years of age
* Confirmed acute cholecystitis diagnosed according to Tokyo 2018 criteria.
* Patient unfit for surgery: if meets one or more of the following criteria: age ≥ 80 years, American Society of Anesthesiology (ASA) ≥ III, Charlson Comorbidity Index \> 5 and/or Karnofsky \< 50, or patient unwilling to undergo surgery.
* Gallbladder drainage by LAMS stent.
* Informed Consent signed

Exclusion Criteria:

* Patient refusal to participate in the study
* Gastrointestinal surgically modified anatomy preventing endoscopic access to the gallbladder.
* Technical failure to perform endoscopic ultrasound guided-gallbladder drainage.
* Moderate or severe ascites.
* Severe coagulopathy International Normalized Ratio \>1.5 and/or fibrinogen \<120) or thrombocytopenia (platelets \<20,000).
* Patient unable to tolerate sedation or general anesthesia
* Haemodynamically unstable patient
* Life expectancy \<6 months
* Baseline ECOG ≥4
* Patient with ongoing malignancy
* Pregnancy
* Acute pancreatitis

Where it's running

  • Hospital General Universitario Dr. Balmis
    Alicante, Alicante, Spain
    Recruiting
  • Hospital Universitario Dr Balmis Alicante
    Alicante, Alicante, Spain
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.